Bastian Dehmel
Corporate Officer/Principal at OCULIS HOLDING AG
Network origin in Bastian Dehmel first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 13 | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden.
6
| Holding Company | Pharmaceuticals: Generic | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Bastian Dehmel via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ANIKA THERAPEUTICS, INC. | Medical Specialties | Director of Finance/CFO | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Oculis SA
 Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | Miscellaneous Commercial Services | Chairman Director/Board Member Chief Executive Officer | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| University of Uppsala | College/University | Undergraduate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Investment Managers | Founder Private Equity Analyst | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
| BAUSCH + LOMB CORPORATION | Medical Specialties | President Sales & Marketing | |
EQT Life Sciences Group BV
 EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Queen's University | College/University | Graduate Degree Doctorate Degree | |
Bankinvest Biomedical Venture
 Bankinvest Biomedical Venture Investment ManagersFinance Bankinvest Biomedical Venture provides investment services. The company was founded in 1998 and is headquartered in Copenhagen, Denmark. | Investment Managers | Corporate Officer/Principal | |
7TM A/S
 7TM A/S Pharmaceuticals: MajorHealth Technology 7TM A/S performs research and development within biotechnology. It engages in clinical development of drugs focusing on obesity and gastrointestinal diseases. The company was founded by Thue Walter Schwartz, Anders Fink Vadsholt, Mette Kirstine Agger, Christian Ellebæk Elling, and Peter Moldt on January 1, 2000 and is headquartered in Hørsholm, Denmark. | Pharmaceuticals: Major | Founder | |
| Boston University | College/University | Masters Business Admin | |
| Copenhagen Business School | College/University | Graduate Degree | |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Masters Business Admin | |
Alpha Healthcare Investments ApS
 Alpha Healthcare Investments ApS Miscellaneous Commercial ServicesCommercial Services Alpha Healthcare Investments ApS provides business and management consulting services. The private company is based in Virum, Denmark. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Massachusetts | College/University | Undergraduate Degree | |
Lakeside Invest ApS
 Lakeside Invest ApS Financial ConglomeratesFinance Lakeside Invest ApS provides financial services. | Financial Conglomerates | Corporate Officer/Principal | |
| Obton Solenergi Sinope Komplementaranpartsselskab | Corporate Officer/Principal | ||
| Copenhagen Innovation Capital Management ApS | Corporate Officer/Principal | ||
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Human Resources Officer | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chief Executive Officer | |
| BIOTAGE AB | Medical Specialties | Director of Finance/CFO | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director of Finance/CFO | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| Simmons University | College/University | Masters Business Admin | |
| AXCA HEALPAR | Biotechnology | Human Resources Officer | |
| Université de Montpellier | College/University | Doctorate Degree | |
| VALNEVA | Biotechnology | Director/Board Member | |
Umecrine AB
 Umecrine AB BiotechnologyHealth Technology Umecrine AB provides pharmaceuticals against mental and physical symptoms. It develops antagonists to reduce symptoms and conditions caused by endogenous sex and stress hormones on the brain. The company was founded by Carl Torbjörn Bäckström in 2000 and is headquartered in Umea, Sweden. | Biotechnology | Director/Board Member | |
| MEDESIS PHARMA S.A. | Biotechnology | Director/Board Member | |
| Intercell Austria AG | Director/Board Member | ||
| ALTAMIRA THERAPEUTICS LTD. | Biotechnology | Director/Board Member | |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| TESARO INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ACTICOR BIOTECH SAS | Biotechnology | Chairman |
Statistics
International
| Denmark | 12 |
| United States | 11 |
| Sweden | 6 |
| Switzerland | 5 |
| Netherlands | 5 |
Sectoral
| Health Technology | 25 |
| Consumer Services | 10 |
| Finance | 6 |
| Commercial Services | 5 |
Operational
| Director/Board Member | 110 |
| Corporate Officer/Principal | 61 |
| Independent Dir/Board Member | 28 |
| Chief Executive Officer | 17 |
| Undergraduate Degree | 15 |
Most connected contacts
| Insiders | |
|---|---|
| Alain Munoz | 38 |
| Martijn Kleijwegt | 33 |
| Lionel Carnot | 27 |
| Anthony Adam Rosenberg | 23 |
| Pravin Dugel | 17 |
| Matthew Gantz | 16 |
| Christina Ackermann | 15 |
| Anders Fink Vadsholt | 13 |
| Virginia R. Dean | 12 |
| Riad Sherif | 9 |
| Rebecca Weil | 9 |
| Geraldine O'Keeffe | 8 |
| Ramin Tadayoni | 7 |
| Sylvia Cheung | 7 |
| Páll Jóhannesson | 5 |
- Stock Market
- Insiders
- Bastian Dehmel
- Company connections
